Qiagen convenes tuberculosis summit. What it means for Qiagen stock

QIAGEN N.V. announced on October 13, 2026, that it would bring together tuberculosis experts for its Global TB Clinical and Educational Summit, citing pressure on global health funding and the continuing need for prevention, screening and care. The announcement was published by Business Wire.

The week in figures

The company’s announcement dated October 13, 2026, said the summit would run through October 16, 2026. No new company financial result or other issuer-reported market figure is included in the reviewed announcement.

Chronology of the week

On October 13, 2026, QIAGEN said the summit would bring together clinicians, laboratory professionals, researchers, advocates and public health leaders. The company said the event would be held online from October 13 through October 15 and in a hybrid format on October 16 at the Royal College of Physicians in London. QIAGEN’s event page also listed more than 35 tuberculosis experts and thousands of attendees. These details are confirmed by QIAGEN.

Weekend trading and next session

The next Xetra session is scheduled for October 19, 2026. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Qiagen stock.

QIAGEN said the summit’s discussions would cover prevention and screening, drug-resistant and childhood tuberculosis, vulnerable populations and access to care. The company also highlighted QuantiFERON-TB Gold Plus as a blood-based test used to detect tuberculosis infection and support clinical evaluation of suspected disease, according to the company release.

Market context: Market report DAX.